Name: New Pharmacological Approaches in Crohn's Disease: Preclinical Study (en Inglés)
Price: 304606.00 COP
Availability: InStock
Author: Mateus, Vanessa ; Sepodes, Bruno ; Pinto, Rui
ISBN: 9786139933761

portada New Pharmacological Approaches in Crohn's Disease: Preclinical Study (en Inglés)

Formato

Libro Físico

Autor

Vanessa Mateus

Bruno Sepodes

Rui Pinto

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

196

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.1 cm

Peso

0.29 kg.

ISBN13

9786139933761

Categorías

Farmacología

New Pharmacological Approaches in Crohn's Disease: Preclinical Study (en Inglés)

Vanessa Mateus (Autor) · Bruno Sepodes (Autor) · Rui Pinto (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 304.606

$ 609.212

Ahorras: $ 304.606

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 05 de Agosto y el Lunes 19 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "New Pharmacological Approaches in Crohn's Disease: Preclinical Study (en Inglés)"

Inflammatory bowel disease is a common gastro-intestinal disorder marked with chronic inflammation of intestinal epithelium, damaging mucosal tissue and manifests into several intestinal and extra-intestinal symptoms. Currently used medical therapy aim to induce and maintain the patient in remission and ameliorate the disease's secondary effects, rather than modifying or reversing the underlying pathogenic mechanism. The main goal of this study is to evaluate the influence of erythropoietin, TDZD-8 and hemin, in a TNBS-induced colitis. Colitic mice are treated with daily doses of erythropoietin, TDZD-8 or hemin. TNBS-induced colitis was developed in 4 days, providing an acute intestinal inflammation model. These mice presented an increase of MPO, TNF-α, IL-1β and fecal hemoglobin. Erythropoietin treatment had a positive influence in the development of experimental colitis in all evaluated parameters, thus reducing its severity and extension. TDZD-8 nd hemin treatments had also a positive influence in the development of experimental colitis, but not in all evaluated parameters. All tested drugs significantly inhibit acute inflammatory response associated to the TNBS-induced colitis.